MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions
View by Date

Wednesday, June 7, 2017

1:15pm-2:45pm
Reappraisal of Progressive Myoclonus Ataxia

S. vd Veen, R. Zutt, T. De Koning, M. Tijssen (Groningen, Netherlands)

Myoclonus  ·  Exhibit Hall C
1:15pm-2:45pm
Relationship between cognitive dysfunction and striatal uptake of 123I-FP-CIT in patients with Parkinson’s disease

H. Sawada, S. Orimo, A. Inaba, M. Takahashi (Tokyo, Japan)

Parkinson's Disease: Cognition  ·  Exhibit Hall C
1:15pm-2:45pm
Relationship between Insulin-like Growth Factor-1 and characteristics of physical activity in patients with Parkinson’s disease

K. Nagaki, M. Ikenaga, S. Fujioka, Y. Tsuboi (fukuoka, Japan)

Parkinson's Disease: Cognition  ·  Exhibit Hall C
1:15pm-2:45pm
Relationship between sensory augmentation and exercise routine in the improvement in balance and gait in a patient with lithium-induced ataxia

M. Maldonado (Santiago, Chile)

Ataxia  ·  Exhibit Hall C
1:15pm-2:45pm
Risk Factors for Dementia in Parkinson’s disease

M.I. Khalil, M.R. Rahman, S. Munira (Dhaka, Bangladesh)

Parkinson's Disease: Cognition  ·  Exhibit Hall C
1:15pm-2:45pm
Role of Apocyanin in modulating glial cell functions and associated inflammatory response in Lipopolysaccharide induced Parkinson’s disease model.

N. Sharma, B. Nehru (Chandigarh, India)

Neuropharmacology  ·  Exhibit Hall C
1:15pm-2:45pm
Rotenone induces astrocyte-mediated non-cell autonomous dopaminergic neurotoxicity

I. Miyazaki, S. Murakami, R. Kikuoka, N. Isooka, Y. Kitamura, M. Asanuma (Okayama, Japan)

Neuropharmacology  ·  Exhibit Hall C
1:15pm-2:45pm
Screening of GBA and LRRK2 G2019S Mutations in Egyptian Parkinson’s Disease Patients

L. R'Bibo, S. Hamed, H. Houlden, N. Wood (London, United Kingdom)

Parkinson's Disease: Genetics  ·  Exhibit Hall C
1:15pm-2:45pm
Segregation of subjective and objective clinical measures in Parkinson’s disease

K. Markopoulou, R. Frigerio, A. Premkumar, B. Schoneburg, M. Dudek, S. Walters, C. Wang, D. Maraganore (Evanston, IL, USA)

Phenomenology and Clinical Assessment Of Movement Disorders  ·  Exhibit Hall C
1:15pm-2:45pm
Self-awareness of cognitive functions in Parkinson’s disease patients with and without mild cognitive impairment.

M. Hoock, F. Maier, R. Kaur, C. Eggers, L. Timmermann (Cologne, Germany)

Parkinson's Disease: Cognition  ·  Exhibit Hall C
  • «Previous Page
  • 1
  • …
  • 27
  • 28
  • 29
  • 30
  • 31
  • …
  • 38
  • Next Page»

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley